Bring context to decisions
Business insights, historical knowledge, and real-time signals are available where decisions are made.
Life sciences organizations are investing heavily in technology, data, and AI. Yet realizing measurable business value requires more than successful technology implementation or product configuration.
Indegene starts with the business outcome, not the technology.
We define the outcomes that matter, then reimagine the processes and capabilities needed to achieve them. This means designing an AI-native future, rather than simply enabling existing ways of working with AI.
We translate this into technology roadmaps rooted in business value, bringing together technology, data, AI, and deep life sciences expertise. Beyond implementation, we address the complexities that determine whether transformation succeeds, including adoption, operating model evolution, and multidimensional change.
The result is not simply successful technology deployment, but sustained value realization.
25%
increase in cost optimization with GenAI
40%
faster campaign delivery
30%
reduction in CRM process delays
Life sciences organizations face no shortage of technology options. New platforms, AI initiatives, data programs, and customer engagement solutions continue to emerge. The challenge is not access to technology. The challenge is connecting technology decisions to business outcomes.
As a result, organizations may successfully deploy technology but still fall short of the outcomes they expected. The gap is not between strategy and execution. It is between business context and technology, data, and AI solutions.
Powered by Cortex, Indegene's reasoning engine, Pharma OS helps organizations:
Business insights, historical knowledge, and real-time signals are available where decisions are made.
Routine tasks are automated while human oversight remains built into critical decisions.
Commercial, medical, marketing, and operations teams work from a shared operating model.
Consistent processes and workflows that drive better coordination, compliance, and operational performance.
Connected data, governance, and technology create the groundwork for enterprise-scale AI.
As organizations move toward AI-native ways of working, the focus will shift from implementing individual technologies to creating operating models that continuously learn, adapt, and improve.
We define business objectives, success measures, operating model implications, and value realization plans. This ensures technology decisions remain grounded in business priorities rather than platform features.
The goal is not implementation success. The goal is sustained business value.
Launch AI agents in life sciences with Indegene's Agentforce Starter Kit, your strategic guide to scalable, data-powered transformation.
Explore how the CDP market is splitting into platformization and agentification, and what it means for pharma engagement.
Discover how Indegene helped a global pharma leader optimize cost by 25% by adopting a structured and scalable AI implementation strategy.
Clear outcomes, measures of success, and accountability from the outset.
Workflows and capabilities reimagined around how people, data, and AI work together.
Life sciences domain, technology, data, AI, and change capabilities working toward common outcomes.
Change embedded into transformation to accelerate adoption and value realization.
Continuous measurement and optimization to ensure value extends beyond implementation.
Business outcomes require shared accountability across business and technology functions, supported by an operating model that establishes common objectives, measures, governance, and ownership from the outset.
The most effective organizations establish shared goals, common metrics, and joint ownership from the outset. Technology discussions should begin with business priorities and desired outcomes, then work backward to the capabilities required to achieve them.
Technology fatigue often occurs when organizations implement new tools without addressing process, adoption, and change management. A business outcome-first approach helps prioritize investments, reduce complexity, and focus on teams on the changes that matter most.
Start by defining the business problem, desired outcomes, and measures of success. Then determine the operating model, process changes, data requirements, and technology capabilities needed to achieve those outcomes. Technology should enable the strategy, not define it.
An AI-native operating model is designed around how people and AI work together from the beginning. Rather than adding AI to existing processes, organizations redesign workflows, governance, data foundations, and decision-making models to take advantage of AI while maintaining appropriate human oversight.
Many technology programs achieve technical deployment but struggle to achieve adoption. Change management helps people understand, embrace, and sustain new ways of working. Without adoption, business value remains unrealized regardless of implementation success.
From platform modernization and cloud transformation to integration, automation, and AI enablement, we help life sciences organizations build resilient, future-ready technology ecosystems that drive measurable outcomes.